The incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer
Context: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. Aims: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conv...
Main Authors: | Rune B Strandby, Lars B Svendsen, Rikard Ambrus, Andreas A Rostved, Jane P Hasselby, Michael P Achiam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Cytology |
Subjects: | |
Online Access: | http://www.jcytol.org/article.asp?issn=0970-9371;year=2020;volume=37;issue=1;spage=40;epage=45;aulast=Strandby |
Similar Items
-
Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy
by: Jiao Ming, et al.
Published: (2023-01-01) -
Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
by: Seyed Amir Aledavood, et al.
Published: (2021-04-01) -
Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis
by: Jing Li, et al.
Published: (2021-03-01) -
Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma
by: Yukinori Kurokawa, et al.
Published: (2023-03-01) -
Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?
by: Eric Zandirad, et al.
Published: (2022-11-01)